A PepGen drug in development for myotonic dystrophy type 1 (DM1) has encouraging early human data that suggest it could be a better treatment than other medicines in clinical testing for this rare, ...
Matthew Herper covers medical innovation — both its promise and its perils. Can a drug that lowers “bad” cholesterol — and also raises the so-called “good cholesterol,” HDL — help to prevent Alzheimer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results